1. Home
  2. KRYS vs CGNX Comparison

KRYS vs CGNX Comparison

Compare KRYS & CGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$345.32

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Cognex Corporation

CGNX

Cognex Corporation

HOLD

Current Price

$66.34

Market Cap

10.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
CGNX
Founded
2015
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
10.7B
IPO Year
2017
1994

Fundamental Metrics

Financial Performance
Metric
KRYS
CGNX
Price
$345.32
$66.34
Analyst Decision
Strong Buy
Buy
Analyst Count
11
11
Target Price
$297.60
$57.91
AVG Volume (30 Days)
242.1K
1.9M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
0.64%
EPS Growth
128.00
9.68
EPS
1.83
0.31
Revenue
$389,130,000.00
N/A
Revenue This Year
$38.74
$9.52
Revenue Next Year
$32.53
$8.63
P/E Ratio
$186.02
$209.08
Revenue Growth
33.94
N/A
52 Week Low
$130.17
$31.42
52 Week High
$347.67
$71.90

Technical Indicators

Market Signals
Indicator
KRYS
CGNX
Relative Strength Index (RSI) 73.08 58.06
Support Level $253.89 $59.00
Resistance Level N/A $70.45
Average True Range (ATR) 12.58 2.66
MACD 3.13 0.01
Stochastic Oscillator 86.78 80.72

Price Performance

Historical Comparison
KRYS
CGNX

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. Geographically, it operates in United states, Europe, Greater China and others. Cognex generates the maximum proportion of its sales in the United States and Europe.

Share on Social Networks: